These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 27606286)

  • 21. Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli.
    Loukiadis E; Nobe R; Herold S; Tramuta C; Ogura Y; Ooka T; Morabito S; Kérourédan M; Brugère H; Schmidt H; Hayashi T; Oswald E
    J Bacteriol; 2008 Jan; 190(1):275-85. PubMed ID: 17873042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of Host Cell Processes by T3SS Effectors.
    Shenoy AR; Furniss RCD; Goddard PJ; Clements A
    Curr Top Microbiol Immunol; 2018; 416():73-115. PubMed ID: 30178263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of Ibe, a novel type III effector protein of A/E pathogens targeting human IQGAP1.
    Buss C; Müller D; Rüter C; Heusipp G; Schmidt MA
    Cell Microbiol; 2009 Apr; 11(4):661-77. PubMed ID: 19134119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoskeleton-modulating effectors of enteropathogenic and enterohemorrhagic Escherichia coli: role of EspL2 in adherence and an alternative pathway for modulating cytoskeleton through Annexin A2 function.
    Tobe T
    FEBS J; 2010 Jun; 277(11):2403-8. PubMed ID: 20477868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.
    Soto E; Espinosa N; Díaz-Guerrero M; Gaytán MO; Puente JL; González-Pedrajo B
    J Bacteriol; 2017 Jan; 199(1):. PubMed ID: 27795324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria.
    Katsowich N; Elbaz N; Pal RR; Mills E; Kobi S; Kahan T; Rosenshine I
    Science; 2017 Feb; 355(6326):735-739. PubMed ID: 28209897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryoelectron-microscopy structure of the enteropathogenic
    Zheng W; Peña A; Ilangovan A; Baghshomali YN; Frankel G; Egelman EH; Costa TRD
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33397726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of espM and espT among enteropathogenic and enterohaemorrhagic Escherichia coli.
    Arbeloa A; Blanco M; Moreira FC; Bulgin R; López C; Dahbi G; Blanco JE; Mora A; Alonso MP; Mamani RC; Gomes TAT; Blanco J; Frankel G
    J Med Microbiol; 2009 Aug; 58(Pt 8):988-995. PubMed ID: 19528152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells.
    Muza-Moons MM; Schneeberger EE; Hecht GA
    Cell Microbiol; 2004 Aug; 6(8):783-93. PubMed ID: 15236645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.
    Navarro-Garcia F; Serapio-Palacios A; Ugalde-Silva P; Tapia-Pastrana G; Chavez-Dueñas L
    Biomed Res Int; 2013; 2013():374395. PubMed ID: 23509714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic Escherichia coli Hijacks GTPase-Activated p21-Activated Kinase for Actin Pedestal Formation.
    Singh V; Davidson A; Hume PJ; Koronakis V
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.
    Glotfelty LG; Zahs A; Hodges K; Shan K; Alto NM; Hecht GA
    Cell Microbiol; 2014 Dec; 16(12):1767-83. PubMed ID: 24948117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.
    Pacheco AR; Lazarus JE; Sit B; Schmieder S; Lencer WI; Blondel CJ; Doench JG; Davis BM; Waldor MK
    mBio; 2018 Jun; 9(3):. PubMed ID: 29921669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli.
    Jayamani E; Mylonakis E
    Virulence; 2014; 5(7):733-9. PubMed ID: 25513774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.
    Long TM; Nisa S; Donnenberg MS; Hassel BA
    Infect Immun; 2014 Jul; 82(7):2802-14. PubMed ID: 24733098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System.
    Guignot J; Segura A; Tran Van Nhieu G
    PLoS Pathog; 2015 Jul; 11(7):e1005013. PubMed ID: 26132339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli.
    Munera D; Martinez E; Varyukhina S; Mahajan A; Ayala-Sanmartin J; Frankel G
    Biochem J; 2012 Aug; 445(3):383-92. PubMed ID: 22587461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.